Petra Otevřelová

Petra Otevřelová

Auto-generated profile, based on publicly available information

Petra Otevřelová

Department of Proteomics Institute of Hematology and Blood Transfusion Prague Czech Republic

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Aleš HoloubekAleš Holoubek
Aleš Holoubek
DSDita Strachotová
Dita Strachotová
KWKateřina Wolfová
Kateřina Wolfová
POPetra Otevřelova
Petra Otevřelova
SBSára Belejová
Sára Belejová
PHPetr Heřman
Petr Heřman
Tumor suppressor p53 is a key player in the cell response to DNA damage that suffers by frequent inactivating aberrations. Some of them disturb p53 oligomerization and influence cell decision between proliferation, growth arrest and apoptosis. Active p53 resides mostly in the nucleus, degradation occurs in the cytoplasm. Acute myeloid leukemia (AML)-related mutation of NPM (NPMmut) induces massive mislocalization of p53 to the cytoplasm, which might be related to leukemia initiation. Since both proteins interact and execute their function as oligomers, we investigated the role of perturbed p53 oligomerization in the p53 mislocalization process in live cells by FLIM (fluorescence lifetime imaging microscopy), fluorescence anisotropy imaging (FAIM), fluorescence cross-correlation spectroscopy (FCCS) and immunochemical methods. On a set of fluorescently labeled p53 variants, monomeric R337G and L344P, dimeric L344A, and multimeric D352G and A353S, we correlated their cellular localization, oligomerization and interaction with NPMmut. Interplay between nuclear export signal (NES) and nuclear localization signal (NLS) of p53 was investigated as well. While NLS was found critical for the nuclear p53 localization, NES plays less significant role. We observed cytoplasmic translocation only for multimeric A353S variant with sufficient stability and strong interaction with NPMmut. Less stable multimer D352G and L344A dimer were not translocated, monomeric p53 variants always resided in the nucleus independently of the presence of NPMmut and NES intactness. Oligomeric state of NPMmut is not required for p53 translocation, which happens also in the presence of the nonoligomerizing NPMmut variant. The prominent structural and functional role of the R337 residue is shown.

3 June 2023 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
KWKateřina Wolfová
Kateřina Wolfová
POPetra Otevřelová
Petra Otevřelová
Aleš HoloubekAleš Holoubek
Aleš Holoubek
BBBarbora Brodská
Barbora Brodská

3 April 2023
Verified
Other
Open access
BBBarbora Brodská
Barbora Brodská
POPetra Otevřelová
Petra Otevřelová
KKKateřina Kuželová
Kateřina Kuželová
Figure S1 Examples of flow-cytometry dotplots Figure S2 Immunofluorescence staining of PD-L1 Figure S3 Correlation of individual mRNA versions

26 September 2026 in The FASEB Journal
Verified
Journal Article
Open access
KWKateřIna Wolfová
KateřIna Wolfová
POPetra OtevřElová
Petra OtevřElová
BBBarbora Brodská
Barbora Brodská
Acute myeloid leukemia (AML) is a heterogeneous disease with large spectrum of specific mutations and gene aberrations. Recently, the Bcl‐2 inhibitor Venetoclax, in combination with hypomethylating agents (HMAs), was approved for older (> 65 years) AML patients, as well as for those unfit for intensive induction chemotherapy. In addition to Bcl‐2 inhibition, Venetoclax also induces generation of reactive oxygen species (ROS). We demonstrated that distinct fraction exhibiting specific features arises during 24 h of sample exposure to Venetoclax. This fraction displays characteristic preapoptotic markers as mitochondria depolarization and partial Annexin V surface positivity. Moreover, monitoring of ROS showed negative correlation between signals detected using H 2 DCFDA and CellROX probes pointing to dynamic ROS changes induced by Venetoclax. The addition of HMA (Decitabine) had almost no effect on cell viability or ROS production but caused proliferation arrest in sensitive cells. In our panel of AML cell lines and primary AML samples we have found a correlation between ROS production, markers of apoptosis, and attenuation of Bcl‐2 activity after Venetoclax treatment. Level of Mcl‐1, another antiapoptotic protein from the Bcl‐2 family, was reduced in sensitive cells, but increased in the resistant samples in response to Venetoclax. Moreover, the nucleolar protein nucleolin (NCL), which is frequently overexpressed in AML cells, was significantly deregulated in Venetoclax‐treated cells. In particular, both NCL protein level and specific phosphorylation decreased in fractions sensitive to Venetoclax. Our findings suggest that Venetoclax targets distinct cell subpopulation, and that ability of a cell to follow increased ROS drives its response to Venetoclax.